UY32849A - Inhibidores heteroarilicos biciclicos de pde4 - Google Patents
Inhibidores heteroarilicos biciclicos de pde4Info
- Publication number
- UY32849A UY32849A UY0001032849A UY32849A UY32849A UY 32849 A UY32849 A UY 32849A UY 0001032849 A UY0001032849 A UY 0001032849A UY 32849 A UY32849 A UY 32849A UY 32849 A UY32849 A UY 32849A
- Authority
- UY
- Uruguay
- Prior art keywords
- pde4
- inhibitors
- heteroarilic
- bicycle
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a compuestos y métodos que pueden ser útiles como inhibidores de f osfodiesterasa 4 (PDE4) . para el tratamiento o la prevención de enfermedades inflamatorias y otras enfermedades que incluyen niveles elevados de citoquinas y mediadores pro inflamatorios.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/544,185 US8138205B2 (en) | 2006-07-07 | 2009-08-19 | Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32849A true UY32849A (es) | 2011-03-31 |
Family
ID=43989737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032849A UY32849A (es) | 2009-08-19 | 2010-08-19 | Inhibidores heteroarilicos biciclicos de pde4 |
Country Status (14)
Country | Link |
---|---|
US (2) | US8138205B2 (es) |
EP (1) | EP2467376A4 (es) |
JP (1) | JP2013502432A (es) |
KR (1) | KR20120051071A (es) |
CN (1) | CN102686578A (es) |
AR (1) | AR078142A1 (es) |
AU (1) | AU2010344165A1 (es) |
BR (1) | BR112012003738A2 (es) |
CA (1) | CA2770767A1 (es) |
CO (1) | CO6612202A2 (es) |
MX (1) | MX2012001695A (es) |
TW (1) | TW201111363A (es) |
UY (1) | UY32849A (es) |
WO (1) | WO2011093924A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8138205B2 (en) * | 2006-07-07 | 2012-03-20 | Kalypsys, Inc. | Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 |
MX2009000148A (es) * | 2006-07-07 | 2009-10-26 | Kalypsys Inc | Inhibidores heteroaril biciclicos de fosfodiesterasa 4. |
CN102548536A (zh) * | 2009-10-01 | 2012-07-04 | 爱尔康研究有限公司 | 奥洛他定组合物及其用途 |
US20130116279A1 (en) * | 2011-11-07 | 2013-05-09 | Kalypsys, Inc. | Bicyclic heteroaryl inhibitors of pde4 |
WO2014128585A1 (en) | 2013-02-19 | 2014-08-28 | Pfizer Inc. | Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders |
WO2016012896A1 (en) | 2014-07-24 | 2016-01-28 | Pfizer Inc. | Pyrazolopyrimidine compounds |
EP3177624B1 (en) | 2014-08-06 | 2019-05-01 | Pfizer Inc | Imidazopyridazine compounds |
WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
CN106916104B (zh) * | 2017-02-28 | 2019-08-27 | 牡丹江医学院 | 用于治疗结肠炎的药物 |
CN117187343A (zh) * | 2023-09-06 | 2023-12-08 | 青岛大学 | 一种磷酸二酯酶抑制剂的高通量筛选方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU639529B2 (en) | 1987-03-04 | 1993-07-29 | Higuchi, Yoshinari | Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives |
CA2091172C (en) | 1990-09-07 | 1997-05-20 | Adriano Afonso | Antiviral compounds and antihypertensive compounds |
DE69231679T2 (de) | 1991-04-03 | 2001-10-31 | Korea Research Institute Of Chemical Technology, Daejeon | 2-chinolinonderivate, verfahren zu deren herstellung und diese enthaltende fungizide und insektizide |
US5412401A (en) * | 1991-04-12 | 1995-05-02 | Abekas Video Systems, Inc. | Digital video effects generator |
IT1296985B1 (it) | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
US20030028018A1 (en) | 2000-09-11 | 2003-02-06 | Chiron Coporation | Quinolinone derivatives |
ES2302106T3 (es) | 2000-09-11 | 2008-07-01 | Novartis Vaccines And Diagnostics, Inc. | Procedimiento de preparacion de derivados de bencimidazol-2-il quinolina. |
JP2002371078A (ja) | 2001-06-12 | 2002-12-26 | Sankyo Co Ltd | キノリン誘導体及びキノロン誘導体 |
US6822097B1 (en) | 2002-02-07 | 2004-11-23 | Amgen, Inc. | Compounds and methods of uses |
ATE432261T1 (de) * | 2002-03-18 | 2009-06-15 | Merck Frosst Canada Ltd | Pde4-inhibitoren mit heterobrückensubstituiertem 8-arylchinolin |
BR0313743A (pt) | 2002-08-23 | 2005-07-05 | Chiron Corp | Benzimidazol quinolinonas e usos destas |
JP5019884B2 (ja) | 2004-02-20 | 2012-09-05 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 炎症プロセスおよび転移プロセスの調節 |
NZ551017A (en) * | 2004-05-18 | 2010-11-26 | Schering Corp | Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
EP1809622B1 (en) | 2004-09-22 | 2010-07-21 | Janssen Pharmaceutica N.V. | Inhibitors of the interaction between mdm2 and p53 |
US8048889B2 (en) | 2005-03-29 | 2011-11-01 | Xtl Biopharmaceuticals Ltd. | 3,4-disubstituted coumarin and quinolone compounds |
NZ566537A (en) | 2005-09-30 | 2010-10-29 | Pulmagen Therapeutics Asthma L | Quinolines and their therapeutic use |
MX2009000148A (es) * | 2006-07-07 | 2009-10-26 | Kalypsys Inc | Inhibidores heteroaril biciclicos de fosfodiesterasa 4. |
US8138205B2 (en) * | 2006-07-07 | 2012-03-20 | Kalypsys, Inc. | Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 |
-
2009
- 2009-08-19 US US12/544,185 patent/US8138205B2/en not_active Expired - Fee Related
-
2010
- 2010-08-19 KR KR1020127006729A patent/KR20120051071A/ko not_active Application Discontinuation
- 2010-08-19 MX MX2012001695A patent/MX2012001695A/es active IP Right Grant
- 2010-08-19 CN CN201080043000XA patent/CN102686578A/zh active Pending
- 2010-08-19 CA CA2770767A patent/CA2770767A1/en not_active Abandoned
- 2010-08-19 AU AU2010344165A patent/AU2010344165A1/en not_active Abandoned
- 2010-08-19 AR ARP100103047A patent/AR078142A1/es unknown
- 2010-08-19 EP EP10844912A patent/EP2467376A4/en not_active Withdrawn
- 2010-08-19 UY UY0001032849A patent/UY32849A/es not_active Application Discontinuation
- 2010-08-19 JP JP2012525683A patent/JP2013502432A/ja active Pending
- 2010-08-19 BR BR112012003738A patent/BR112012003738A2/pt not_active IP Right Cessation
- 2010-08-19 TW TW099127743A patent/TW201111363A/zh unknown
- 2010-08-19 WO PCT/US2010/045997 patent/WO2011093924A1/en active Application Filing
-
2012
- 2012-02-10 US US13/370,756 patent/US20130045975A1/en not_active Abandoned
- 2012-02-17 CO CO12028570A patent/CO6612202A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2011093924A1 (en) | 2011-08-04 |
EP2467376A4 (en) | 2013-01-16 |
BR112012003738A2 (pt) | 2019-09-24 |
JP2013502432A (ja) | 2013-01-24 |
AR078142A1 (es) | 2011-10-19 |
CN102686578A (zh) | 2012-09-19 |
US8138205B2 (en) | 2012-03-20 |
AU2010344165A1 (en) | 2012-03-01 |
TW201111363A (en) | 2011-04-01 |
CA2770767A1 (en) | 2011-08-04 |
KR20120051071A (ko) | 2012-05-21 |
MX2012001695A (es) | 2012-07-23 |
CO6612202A2 (es) | 2013-02-01 |
EP2467376A1 (en) | 2012-06-27 |
US20130045975A1 (en) | 2013-02-21 |
US20100081646A1 (en) | 2010-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32849A (es) | Inhibidores heteroarilicos biciclicos de pde4 | |
UY32110A (es) | Inhibidores de aminopirimidina de los receptores de histamina para el tratamiento de una enfermedad | |
UY32111A (es) | Inhibidores heterociclicos de los receptores de histamina para el tratamiento de una enfermedad | |
UY33272A (es) | Inhibidores heterocíclicos de los receptores de histamina para el tratamiento de una enfermedad | |
UY33271A (es) | Inhibidores heterocíclicos de los receptores de histamina para el tratamiento de una enfermedad | |
CR20110257A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes | |
NZ730134A (en) | Substituted tricyclic compounds as fgfr inhibitors | |
GT201400178A (es) | Compuestos de oxazolidin-2-ona y usos de los mismos como inhibidores de la pi3ks | |
TR201901886T4 (tr) | DNA-PK inhibitörleri. | |
CR11818A (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
CO6430459A2 (es) | Derivados de prolina como inhibidores de catepsina | |
MX2009000148A (es) | Inhibidores heteroaril biciclicos de fosfodiesterasa 4. | |
MX368959B (es) | Inhibidores heteroarilo de pde4. | |
PE20121617A1 (es) | Derivados de oxazina como inhibidores de bace | |
UY33314A (es) | Derivados de acido 1-amino-2-ciclopropiletilboronico | |
ES2525801T8 (es) | Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes | |
CR20110046A (es) | Amidofenoxiindazoles utiles como inhibidores de c-met | |
EA201101477A1 (ru) | Органические соединения и их применение | |
CR9347A (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
ECSP13012824A (es) | Derivados de (1,2,4)triazolo[4,3-a)quinoxalina como inhibidores de fosfodiesterasas | |
MX2009013353A (es) | Compuestos activadores de telomerasa y metodos para su uso. | |
UY32291A (es) | Inhibidores de quinasa con perfiles de seguridad cyp mejorados | |
MX2010005114A (es) | Uso de las soluciones de aceite de menta o de l-carvona para el tratamiento fungicida y/o antigerminacion de bulbos y/o tuberculos. | |
MX2016003823A (es) | Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma. | |
CA2929436C (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20181127 |